Comparative Proteome Identifies Complement Component 3-Mediated Immune Response as Key Difference of Colon Adenocarcinoma and Rectal Adenocarcinoma
Colorectal cancer (CRC) is one of the most lethal diseases with high morbidity and mortality worldwide. Clinically, tumors located in colon and rectum have diverse prognosis and therapeutic outcome. Here, we performed data mining derived from 20 CRC patient samples to compare proteomic difference be...
Main Authors: | Jun-Ze Liang, Xiao-Ling Liang, Li-Ye Zhong, Chu-Tian Wu, Jing Zhang, Yang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.617890/full |
Similar Items
-
Synchronous Adenocarcinoma of the Colon and Rectal Carcinoid
by: Vamshidhar Vootla, et al.
Published: (2016-10-01) -
Rectal adenocarcinoma in an 9 year old girl. A case report
by: Hedayatollah Nahvi, et al.
Published: (2018-12-01) -
Proteomic Analysis of Protein Ubiquitination Events in Human Primary and Metastatic Colon Adenocarcinoma Tissues
by: Yi Zhang, et al.
Published: (2020-09-01) -
Identification of Metabolic-Associated Genes for the Prediction of Colon and Rectal Adenocarcinoma
by: Cui Y, et al.
Published: (2021-03-01) -
Adenocarcinoma in Colonic Interposition
by: Shahar Grunner, et al.
Published: (2013-03-01)